Clinical research involving infants, children, and adolescents is, in many respects, more challenging than research involving adults. While clinical trial enrollment is already challenging, the aspects of parental involvement, family decision making and supporting the physical and emotional needs of children and caregivers add to the many enrollment complexities faced by so many pediatric trials today.
In this webinar, our experts will cover best practices for recruitment and retention for pediatric studies including:
- Defining and understanding the mindsets of parents and children regarding clinical research and trial opportunities
- Quickly revisiting successful communication and customer service strategies for parents, caregivers and children
- Providing recruitment awareness and education, as well as compliance, retention, and appreciation support to pediatric trial participants
- Exploring the increased need for compliance and retention strategies, and to keep up with the “tech savvy” young populations around the world
- Ensuring that caregivers are supported and feel confident and informed throughout every step of the process, even when their child is more “tech savvy’ than them
During the webinar, our speakers will focus on discussing relevant content and case studies about how to address the unique needs of studies involving pediatric patients and caregivers in the following types of studies:
- Rare disease studies
- Inpatient setting studies
- Chronic studies
- A special look at the variation needed to meet a wide range of pediatric patient age groups
Nikki Fink, Director of Patient Access and Retention Services, PRA Health Sciences
Nikki brings 17 years of recruitment specific clinical research experience, having held senior patient recruitment roles at Quintiles and PPD, working as a pharmaceutical recruitment consultant for Arthur Andersen LLP, and then leading N. America patient recruitment operations for GlaxoSmithKline. To round out her recruitment and retention expertise, she later worked as a senior strategist for a global patient recruitment supplier before returning to the CRO industry where she has been Director of Patient Access & Retention Services with PRA Health Sciences since 2010. She brings a unique mix of CRO, sponsor and supplier experience and has worked on 45 pediatric recruitment and retention programs spanning multiple therapeutic areas.
She is located outside of Raleigh, NC and is a proud graduate of the University of Florida with a BS in Communications.
Kate Hersov, MD, Founder, Jumo Health
Dr. Kate Hersov is founder of Jumo. Kate qualified as a doctor in 2004 after graduating from the University of Otago, New Zealand. She worked in Emergency Medicine and Pediatrics before leaving medicine, and New Zealand, to co-found Jumo. Jumo was launched in the UK in 2009 and is the world’s first medical education company for children.
Jumo has been awarded the DTC National Advertising Awards 2016, Gold Mom’s Choice Award, London Business Innovation of the Year, shortlisted for IPG Newcomer of the Year, named in the Startups 100 list and been accredited with the United Kingdom Department of Health’s Information Standard. Kate has herself been awarded the PharmaVoice 100 Most Influential People in Healthcare, the Desmond Tutu Global Achievement Award for Excellence, CNBC’s UK’s Tech Industry Top Women Entrepreneurs, Management Today’s ’35 leading Women Under 35′ and Woman of the Future ‘Entrepreneur of the Year’.
Jumo is a global health care education company with offices in New York, London, and Sydney. Founded to alleviate the fear and uncertainty of children that often accompanies a clinical diagnosis, Jumo creates comic books, videos, podcasts, and apps that help children and their families better understand and manage their health and wellness. Jumo products provide individuals with the ability to learn in their way, on their terms, throughout their medical journey. To learn more about Jumo, please visit www.JumoHealth.com.
Who Should Attend?
Executives and managers in pharma and biotech in:
- Strategic drug development
- Clinical operations
- Outsourcing and procurement
- Clinical trial planning and optimization
- Patient recruitment and retention
What You Will Learn
Viewers will have the opportunity to learn about techniques and see real-life examples used to improve the pediatric and caregiver trial experience for all stakeholders involved.
PRA Health Sciences
PRA Health Sciences delivers innovative drug development solutions that improve patients’ lives. Our people love what they do, working tirelessly for clients across all phases and therapeutic areas. With 13,000+ employees covering 85+ countries, we provide an impressive global presence and in-depth knowledge of local regulations, standards of care and cultural customs.
With a wealth of experience across neurological, psychiatric, and analgesic drug development, including pediatric and rare indications. PRA Health Sciences is an industry-leader in providing innovative clinical research solutions. PRA has carried out the pivotal trials leading to the approval of 20 drugs for the treatment, prevention and cure of neurological, psychiatric and pain disorders under the expert guidance of the 15+ Board Certified Neurologists and Psychiatrists we have on staff. We are dedicated to gathering quality, actionable data to advance clinical research, with a strong focus on the patient journey.